1. Home
  2. OLMA vs FFIC Comparison

OLMA vs FFIC Comparison

Compare OLMA & FFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • FFIC
  • Stock Information
  • Founded
  • OLMA 2006
  • FFIC 1929
  • Country
  • OLMA United States
  • FFIC United States
  • Employees
  • OLMA N/A
  • FFIC N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • FFIC Major Banks
  • Sector
  • OLMA Health Care
  • FFIC Finance
  • Exchange
  • OLMA Nasdaq
  • FFIC Nasdaq
  • Market Cap
  • OLMA 378.9M
  • FFIC 408.4M
  • IPO Year
  • OLMA 2020
  • FFIC 1995
  • Fundamental
  • Price
  • OLMA $7.89
  • FFIC $13.87
  • Analyst Decision
  • OLMA Strong Buy
  • FFIC
  • Analyst Count
  • OLMA 5
  • FFIC 0
  • Target Price
  • OLMA $24.00
  • FFIC N/A
  • AVG Volume (30 Days)
  • OLMA 1.0M
  • FFIC 191.9K
  • Earning Date
  • OLMA 11-11-2025
  • FFIC 10-23-2025
  • Dividend Yield
  • OLMA N/A
  • FFIC 6.27%
  • EPS Growth
  • OLMA N/A
  • FFIC N/A
  • EPS
  • OLMA N/A
  • FFIC N/A
  • Revenue
  • OLMA N/A
  • FFIC $137,137,000.00
  • Revenue This Year
  • OLMA N/A
  • FFIC $113.87
  • Revenue Next Year
  • OLMA N/A
  • FFIC $5.75
  • P/E Ratio
  • OLMA N/A
  • FFIC N/A
  • Revenue Growth
  • OLMA N/A
  • FFIC N/A
  • 52 Week Low
  • OLMA $2.86
  • FFIC $10.65
  • 52 Week High
  • OLMA $13.93
  • FFIC $18.59
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 66.97
  • FFIC 62.31
  • Support Level
  • OLMA $7.49
  • FFIC $13.27
  • Resistance Level
  • OLMA $8.25
  • FFIC $13.83
  • Average True Range (ATR)
  • OLMA 0.66
  • FFIC 0.26
  • MACD
  • OLMA 0.12
  • FFIC -0.00
  • Stochastic Oscillator
  • OLMA 80.06
  • FFIC 67.42

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

Share on Social Networks: